Ramipril treatment in a patient with glycogen storage disease I non-A

M. L. Gianni, M. Bonvissuto, M. Gallieni, C. Testolin, E. Racchi, E. Riva

Research output: Contribution to journalArticlepeer-review


We studied the effect of ramipril on proteinuria and mild hypertension in a 21-year-old patient affected by glycogen storage disease type I non-A. After few months of therapy we obtained a decrease in total urine protein excretion that later re-increased in spite of the high dose of ACE inhibitor. Even if ACE inhibitors are the only effective therapy for GSD I nephropathy, further studies are requested.

Original languageEnglish
Pages (from-to)515-516
Number of pages2
JournalJournal of Inherited Metabolic Disease
Issue number6
Publication statusPublished - Oct 2002

ASJC Scopus subject areas

  • Endocrinology
  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Ramipril treatment in a patient with glycogen storage disease I non-A'. Together they form a unique fingerprint.

Cite this